Samsung Biologics Acquires GSK U.S. Manufacturing Site
INCHEON, South Korea & ROCKVILLE, Maryland, USA — March 31, 2026 Samsung Biologics has officially completed the acquisition of...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
INCHEON, South Korea & ROCKVILLE, Maryland, USA — March 31, 2026 Samsung Biologics has officially completed the acquisition of...
Brussels, Belgium & Atlanta, Georgia – March 24, 2026 Strategic Biologics Expansion to Strengthen Global Supply In a major...
Parsippany, New Jersey, USA | March 19, 2026 Embecta Corp. has announced a definitive agreement to acquire Owen Mumford...
CAMBRIDGE, England & BOSTON — December 16, 2025 — Bicycle Therapeutics plc, a clinical-stage pharmaceutical company pioneering bicyclic peptide–based...
MENLO PARK, CA — November 20, 2025 — Antheia announced a strategic partnership with TAPI (Teva Active Pharmaceutical Ingredients)...
WAUKESHA, WI – November 11, 2025 — Lifeway Foods, Inc. (NASDAQ: LWAY), a leading U.S. supplier of kefir and...
OTTAWA, Oct. 2, 2025 — Kinaxis announced that Sobi, a specialist in rare‐disease biopharma, will adopt the Kinaxis Maestro®...
Hyderabad, India — September 18, 2025 — Sai Life Sciences has inaugurated Unit VI, a dedicated facility for the...
